At the time of writing, Johnson & Johnson [JNJ] stock is trading at $167.93, up 2.17%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The JNJ shares have gain 8.22% over the last week, with a monthly amount glided 12.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on May 13, 2025, when Leerink Partners downgraded its rating to a Market Perform but kept the price target unchanged to $153 for it. On November 15, 2024, Wolfe Research initiated with a Outperform rating and assigned a price target of $190 on the stock. Daiwa Securities downgraded its rating to a Neutral and decreased its price target to $150 on July 23, 2024. HSBC Securities upgraded its rating to Buy for this stock on April 18, 2024, but kept the price target unchanged to $170. In a note dated December 13, 2023, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $170 to $163.
For the past year, the stock price of Johnson & Johnson fluctuated between $140.68 and $169.99. Currently, Wall Street analysts expect the stock to reach $164 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $167.93 at the most recent close of the market. An investor can expect a potential drop of -2.34% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
According to Johnson & Johnson [NYSE:JNJ], the company’s sales were 90.63B for trailing twelve months, which represents an 5.77% jump. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at 0.41%, and Net Profit Margin reading is 0.34%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.31 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 165.74 points at the first support level, and at 163.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 169.09, and for the 2nd resistance point, it is at 170.24.
Ratios To Look Out For
It is important to note that Johnson & Johnson [NYSE:JNJ] has a current ratio of 1.26. Further, the Quick Ratio stands at 1.03, while the Cash Ratio is 0.68. Considering the valuation of this stock, the price to sales ratio is 4.46, the price to book ratio is 5.17 and price to earnings (TTM) ratio is 17.96.
Transactions by insiders
Recent insider trading involved REED JOHN C, EVP, Innovative Medicine, R&D, that happened on Jul 17 ’25 when 19137.0 shares were sold. Officer, REED JOHN C completed a deal on Jul 17 ’25 to buy 19137.0 shares. Meanwhile, VP Corporate Controller Decker Robert J sold 6999.0 shares on Feb 25 ’25.
